This content was published in 2013. We do not recommend that you take any clinical decisions based on this information without first ensuring you have checked the latest guidance.
Objectives
Studying this article will help you to:
- Recognise the signs and symptoms of hyperemesis and the point at which a woman needs referral
- Recommend non-pharmacological strategies for women with hyperemesis
- Recommend safe and effective treatment for hyperemesis and consider safe prescribing in pregnancy
Although it has many different definitions, hyperemesis gravidarum (HG) essentially constitutes severe nausea and vomiting in pregnancy (NViP) that leads to dehydration or ketonuria that is severe enough to warrant admission to hospital (see Box 1). It typically starts during the first trimester (between five and 10 weeks into the pregnancy) and resolves by about week 20.
It is a diagnosis of exclusion so differential diagnoses must be explored and excluded before a formal diagnosis of HG can be made.1 Possible differential diagnoses include:
- Gestational trophoblastic disease
- Hyperthyroidism
- Urinary tract infection
- Migraine
- Diseases affecting the ear, nose or throat (eg, labyrinthitis)
- Gastrointestinal disease (eg, peptic ulcer)
- Psychological disorders
The cause may also be iatrogenic (eg, due to iron administration).
HG can be life-threatening to both mother and fetus, albeit rarely, due to electrolyte or pH imbalances, Wernicke’s encephalopathy or thrombosis.
Up to 80% of pregnant women suffer from nausea and vomiting; only 0.3–1.5% suffer with HG — of these, 10% continue to have problems throughout pregnancy.
Recent studies, although somewhat conflicting, suggest that women are more likely to suffer with HG if they are:
- Giving birth for the first time (primiparous)
- From a lower socioeconomic background
- Young
- Non-smokers
- Obese or underweight
The causes of HG are complex and likely to be multifactorial. It is well recognised that, during pregnancy, there is an increase in fluid secretions from the upper gastrointestinal tract. It is also likely that the incidence of Helicobacter pylori is higher among HG sufferers.2
Furthermore, because human chorionic gonadotrophin is of similar structure to thyroid-stimulating hormone, the normal physiology of thyroid function may be altered — resulting in transient hyperthyroidism. Other psychological and social factors have also been found to be relevant.
Management
Severe cases of HG should be managed in hospital. However, there is a lack of published evidence on where to manage patients with NViP or the effect the location might have on their outcome. Nonetheless, it has been widely proposed that day-case or outpatient settings are likely to be appropriate.
In general, patients with NViP fall into three groups according to the severity of their symptoms. These are:
- Mild with no signs of dehydration — suitable for management in primary care
- Moderate with some signs of mild dehydration — requiring day-case treatment with intravenous therapy
- Severe — needing hospital admission and further assessment for HG
Scoring systems exist for recording vomiting symptoms,3 but not for guiding the best location of management. A hyperemesis intervention system score is currently being evaluated at Portsmouth Hospitals NHS Trust. The system considers a patient’s hydration and clinical state and acts as a triage system to determine the most appropriate location of initial treatment — primary care, hospital day-case or hospital admission.
Effective management requires a multidisciplinary approach that considers individual circumstances and severity of symptoms. Management should include both pharmacological and non-pharmacological interventions, influenced by the care setting and the availability of treatment options.
Pharmacological management
Fluids
Intravenous fluid and electrolyte replacement form the mainstay of treatment for patients treated in hospital. In severe cases, parenteral nutrition may be indicated. Non-glucose containing fluids (eg, sodium chloride 0.9%, Hartmann’s) are the fluids of choice — to reduce the risk of precipitating Wernicke’s encephalopathy.
Oral rehydration therapy may be appropriate in primary care to help prevent an admission. Women treated in this way should be monitored closely and advised to seek help if symptoms persist.
Antiemetics
The decision to use antiemetics should only be considered once the woman has been advised of the associated risks and benefits. Where indicated, antiemetics should be introduced in a stepwise approach and continued only as long as required (see Box 2).
Vitamins
Women suffering with nausea and vomiting for prolonged periods may benefit from thiamine supplements (orally or, in severe cases, intravenously) to reduce the risk of Wernicke’s encephalopathy. Folic acid (5mg daily) should also be considered — particularly during the first trimester.
For discussion
- There has recently been a Medicines and Healthcare products Regulatory Agency alert on the neurological toxicity of metoclopramide. What impact might this have when prescribing for this patient group?
- When prescribing medicines in pregnancy, what factors should be considered?
- Other than oral, what routes of administration for antiemetics can be used in primary care for women who are vomiting?
Non-pharmacological treatment
Dietary and lifestyle advice
Since robust clinical evidence is lacking, advice surrounding diet and lifestyle is based primarily on anecdotal evidence. Nonetheless, many women find that simple changes to their diet and lifestyle can help to ease symptoms.
Women should be advised to drink and eat “little and often” — avoiding three larger meals per day in favour of smaller snacks that are rich in carbohydrate and protein. Spicy foods that are high in fat or very acidic are best avoided. For some women, cold food may be tolerated better than hot food. Women should be encouraged to rest because fatigue may exacerbate symptoms.
Emotional support
Women with HG can feel isolated and anxious. It is important that they feel supported by healthcare professionals and that their condition is understood. Depression in early pregnancy has been shown to aggravate HG.
Studies investigating the effects of increased interaction with midwives, and other healthcare professionals, suggest that offering advice, reassurance and listening to their concerns may give women the confidence to manage their symptoms at home.4
Acupressure
Small studies have shown that acupressure on the P6 acupoint (on the inside of the wrist) may benefit some HG sufferers. This technique is recommended by the National Institute for Health and Care Excellence.5
Ginger
Ginger is believed to reduce the symptoms of HG. Although the exact mechanism is unknown, studies suggest it may increase gastrointestinal motility or act directly on the chemoreceptor trigger zone.
Furthermore, according to the UK Teratology Information Service, it has not been shown to have teratogenic effects. Women can opt for ginger supplements or may prefer to try ginger biscuits or ginger ale.
References
- Verberg M, Gillott D, Al-Fardan N, et al. Hyperemesis gravidarum, a literature review. Human Reproduction Update 2005;11:527–39.
- Mansour G, Nashaat E. Role of Helicobacter pylori in the pathogenesis of hyperemesis gravidarum. Archives of Obstetrics and Gynecology 2011;284:843–7.
- Lacasse A, Rey E, Ferreira E, et al. Validity of a modified pregnancy-unique quantification of emesis and nausea scoring index to assess severity of nausea and vomiting of pregnancy. American Journal of Obstetrics and Gynaecology 2008. www.ajog.org (accessed 4 November 2013).
- Munch S, Schmitz M. Hyperemesis gravidarum and patient satisfaction: a path model of patients’ perceptions of the patient-physician relationship. Journal of Psychosomatic Obstetrics and Gynaecology 2006;27:49–57.
- National Institute for Health and Care Excellence. Antenatal care. March 2008. www.nice.org.uk/cg62 (accessed 4 November 2013).
